Susquehanna International Group’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Hold |
0
| – | – | – | 5334 |
|
|
2018
Q1 | – | Sell |
-784,744
| Closed | -$1.3M | – | 5165 |
|
|
2017
Q4 | $1.3M | Buy |
+784,744
| New | +$1.3M | ﹤0.01% | 1534 |
|
|
2017
Q3 | – | Sell |
-26,428
| Closed | -$43K | – | 4807 |
|
|
2017
Q2 | $43K | Buy |
+26,428
| New | +$43K | ﹤0.01% | 3356 |
|
|
2017
Q1 | – | Sell |
-7,022
| Closed | -$36K | – | 5010 |
|
|
2016
Q4 | $36K | Sell |
7,022
-2,219
| -24% | -$11.4K | ﹤0.01% | 4016 |
|
|
2016
Q3 | $233K | Sell |
9,241
-4,820
| -34% | -$122K | ﹤0.01% | 2484 |
|
|
2016
Q2 | $348K | Buy |
14,061
+11,997
| +581% | +$297K | ﹤0.01% | 2405 |
|
|
2016
Q1 | $60K | Sell |
2,064
-9,192
| -82% | -$267K | ﹤0.01% | 3629 |
|
|
2015
Q4 | $418K | Buy |
11,256
+1,275
| +13% | +$47.3K | ﹤0.01% | 3142 |
|
|
2015
Q3 | $486K | Sell |
9,981
-14,951
| -60% | -$728K | ﹤0.01% | 3127 |
|
|
2015
Q2 | $1.72M | Buy |
24,932
+18,694
| +300% | +$1.29M | ﹤0.01% | 2044 |
|
|
2015
Q1 | $223K | Buy |
6,238
+3,372
| +118% | +$121K | ﹤0.01% | 3684 |
|
|
2014
Q4 | $36K | Sell |
2,866
-10,557
| -79% | -$133K | ﹤0.01% | 4301 |
|
|
2014
Q3 | $206K | Buy |
13,423
+9,702
| +261% | +$149K | ﹤0.01% | 3508 |
|
|
2014
Q2 | $101K | Buy |
3,721
+2,275
| +157% | +$61.8K | ﹤0.01% | 4026 |
|
|
2014
Q1 | $39K | Buy |
1,446
+33
| +2% | +$890 | ﹤0.01% | 3449 |
|
|
2013
Q4 | $35K | Buy |
+1,413
| New | +$35K | ﹤0.01% | 3833 |
|